Wednesday 19 November 2008 @ 9:11 am
|
The Rocky Legal Landscape of Virtual Worlds, Part 2: Patents
TechNewsWorld, CA - By Ross Dannenberg and Steve Chang The path to obtaining a patent on the type of software used to enliven virtual worlds can be circuitous, … Online Startup Aims To Improve Patent Quality |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Wednesday 19 November 2008 @ 7:11 am
![]() WELT ONLINE |
Sanofi settles some Allegra, Nasacort patent suits
MarketWatch - By Geraldine Amiel Sanofi said in a statement that its US unit Sanofi-Aventis US agreed to grant Barr and Tevca a license to certain patent rights, … AMRI settles patent dispute with rivals Sanofi Settles Patent Dispute With Barr, Teva on Allergy Drugs Sanofi settles on Allegra, Nasacort generics in US |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Wednesday 19 November 2008 @ 7:11 am
|
AstraZeneca: FDA approves generic Pulmicort Respules
MarketWatch - With FDA approval of the generic drug, Teva has the option to launch "at risk" without waiting for the resolution of the patent case. … FDA approves generic version of Astra asthma drug Teva gets FDA approval for generic asthma drug Teva Starts Commercial Launch of Generic Astrazeneca Drug |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Wednesday 19 November 2008 @ 7:11 am
![]() enterpriser.in |
Microsoft and Novell at two: Was the patent pact worth it?
ZDNet Blogs - In the first few months after Novell and Microsoft announced their deal, Microsoft convinced a number of smaller Linux players they needed similar “patent… The Microsoft-Novell Linux deal: Two years later 'Moonlight' heads to beta Microsoft, Novell See … |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Wednesday 19 November 2008 @ 7:11 am
|
Court Stays Patent Infringement Suit Brought against Candela by …
MarketWatch - announced today that the United States District Court for the District of Massachusetts agreed to stay the patent litigation that Palomar Medical … Court Stays Hair Removal Patent Suit Palomar's Hair Removal Lawsuit Against Candela Stayed Pending Re … |
More: continued here
Powered by SmartRSS
Wednesday 19 November 2008 @ 6:11 am
|
Konstantinos Andrikopoulos, Ph.D., JD, Joins RXi Pharmaceuticals …
MarketWatch - He brings a wealth of both small and large company experience as well as a broad scientific and patent law background. Konstantinos will help strengthen our … |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Wednesday 19 November 2008 @ 6:11 am
![]() Computerworld |
Kodak sues LG and Samsung over alleged patent violations
Ars Technica, MA - One of the patents in question, US Patent 5016107, covers digital still cameras that use image compression and digital storage, which includes just about … UPDATE:Samsung Elec,LG To Actively Deal With US Patent Cases Spansion, Kodak file patent suits against Samsung Spansion Sues Samsung in One of Technology Industry's Largest … |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Wednesday 19 November 2008 @ 6:11 am
|
This Offshoring Patent Services to India Report is Now Available
MarketWatch - Revenues from the Indian patent services offshoring industry are estimated at $46 m for the calendar year 2007 and are expected to reach $206 m by end 2012. … |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Wednesday 19 November 2008 @ 6:11 am
|
Novartis prepares for looming loss of diovan patent
MarketWatch - … prepare for the expected loss of revenue when the patent of its best-selling drug Diovan will expire in four years, the Swiss drugmaker said Wednesday. … Novartis to Focus on Biologic Drugs as Generics Loom (Update1) UPDATE 2-US asks for more data on Novartis cancer drug Novartis to Combine Heart Pills as Afinitor Cancer Drug Delayed |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Wednesday 19 November 2008 @ 6:11 am
|
VocalTec Announces Third Quarter 2008 Results
MarketWatch - Operating expenses for the third quarter of 2008 and for the nine months ended September 30, 2008, excluding income from the patent sale, were $2.7 million … |
More: continued here
If you like this post, please buy me a beer for $3 8-)





















